A potential treatment strategy might involve the inhibition of PI3K/Akt pathway which can help reduce tumour growth and sensitise cancer cells to immune attack and administer an immune checkpoint inhibitor concurrently, to recognize and attack cancer cells more effectively. The gene discussed is AKT1; the disease is neoplasm.